David Arnar, EHRA 2019 – Asymptomatic Arrhythmias скачать в хорошем качестве

David Arnar, EHRA 2019 – Asymptomatic Arrhythmias

At the EHRA 2019 congress in Lisbon, Dr David Arnar (Chief of Cardiology, Landspitali, the National University Hospital of Iceland, Reykjavik, Iceland) joins us to discuss the latest insights into understanding asymptomatic arrhythmias and managing them in routine practice. Filmed at EHRA 2019, Lisbon. Speaker's Disclosures: Dr David Arnar is a consultant to Decode Genetics. Questions: 1. How common are asymptomatic arrhythmias? (0:14) 2. How do asymptomatic arrhythmias and paroxysmal symptomatic atrial fibrillation differ in terms of risk of stroke or systemic embolism? (0:51) 3. How does the presence of subclinical atrial fibrillation affect treatment and management decisions for your patients? (1:24) 4. How does atrial fibrillation ablation affect asymptomatic arrhythmias? (2:29) 5. What are the benefits of screening for asymptomatic arrhythmias and how should this be approached? (3:47) 6. What work remains to be done in better understanding asymptomatic arrhythmias and how to manage them in routine practice? (4:45) touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.